Mark F. Lew, MD, received his medical degree from George Washington University in Washington DC, where he also served his Internship in Internal Medicine. He completed his Residency in Neurology at Los Angeles County+University of Southern California Medical Center and his Fellowship in Movement Disorders at the University of Southern California in Los Angeles. He is a Fellow of the American Academy of Neurology and holds Board Certification from the American Board of Psychiatry and Neurology.
Dr. Lew joined the faculty of the Keck School of Medicine of the University of Southern California in 1991, where he now holds the position of Professor of Neurology, Vice Chair of the department of Neurology and Director of the Division of Movement Disorders. At present, he is also the Director of the Movement Disorders Clinic at Los Angeles County+University of Southern California Medical Center. He also holds the Joseph P. Van Der Meulen Chair in Parkinson’s Disease Research in honor of Robert Pasarow.
Dr. Lew is currently focusing on research in new pharmacologic treatments for Parkinson's disease and dystonia. His research in evaluating tears as a potential biomarker in Parkinson’s disease has been presented internationally and published in Biomarkers in Medicine. In addition, he is conducting clinical trials using new forms of botulinum toxin to treat focal dystonias. He is a Participating Scientist of both the Parkinson's Study Group and the Dystonia Study Group and is on the Medical Advisory Committee of the Musicians with Dystonia Program. He has also directed the dystonia clinic at the USC/LACH since 1991.
He is an author on more than 125 peer reviewed articles on PD, dystonia and other movement disorders. He has served on the Board of Directors of the USC-CRO.